Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$79
|
$223B |
3.5x |
8.2x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$167B |
2.6x |
6.9x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€90
|
$128B |
2.7x |
9.1x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£13
|
$84.7B |
2.1x |
6.0x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 233
|
$81.6B |
5.3x |
15.9x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€133
|
$28.6B |
4.2x |
16.2x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 68
|
$11.2B |
25.7x |
71.9x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 23
|
$8.4B |
2.1x |
15.5x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2747
|
$5.2B |
11.8x |
38.8x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$97
|
$5.1B |
1.8x |
-4.0x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 141
|
$4.6B |
5.5x |
20.7x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$26
|
$3.9B |
1.3x |
-1.0x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 17
|
$3.8B |
6.2x |
14.5x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 39
|
$2.7B |
7.4x |
41.9x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.7B |
66.0x |
N/A |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 14
|
$2.5B |
5.9x |
19.5x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 8478
|
$2.4B |
N/A |
N/A |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$31
|
$2.3B |
N/A |
N/A |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 11
|
$2.0B |
4.7x |
14.3x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 48
|
$1.9B |
14.8x |
-20.5x |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 38750
|
$1.5B |
6.0x |
-25.0x |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 146
|
$1.3B |
1.6x |
5.5x |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 23
|
$1.3B |
N/A |
N/A |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 12732
|
$1.1B |
N/A |
N/A |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 16
|
$1.1B |
5.7x |
7.7x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 60
|
$1.0B |
N/A |
N/A |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$936M |
3.2x |
21.8x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 7
|
$917M |
N/A |
N/A |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 16
|
$890M |
6.1x |
12.7x |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€24
|
$882M |
N/A |
N/A |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 3
|
$688M |
3.8x |
N/A |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 25
|
$688M |
2.9x |
10.1x |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 8
|
$683M |
N/A |
N/A |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 7
|
$663M |
15.2x |
N/A |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 499
|
$613M |
N/A |
N/A |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 25
|
$591M |
N/A |
N/A |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€3
|
$535M |
2.8x |
39.8x |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 7
|
$490M |
N/A |
N/A |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 446
|
$484M |
N/A |
N/A |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$405M |
57.7x |
-1.4x |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$403M |
N/A |
N/A |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$17
|
$396M |
65.4x |
-2.0x |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 2
|
$373M |
6.8x |
-20.4x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$352M |
4.8x |
-13.7x |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 40
|
$350M |
N/A |
N/A |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$341M |
90.6x |
-18.8x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 23
|
$285M |
1.7x |
8.1x |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$6
|
$250M |
0.4x |
-2.0x |
Coherus BioSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$241M |
1.1x |
-2.1x |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 22
|
$234M |
N/A |
N/A |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 18
|
$230M |
N/A |
N/A |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 44
|
$212M |
N/A |
N/A |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$209M |
N/A |
N/A |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$176M |
60.6x |
N/A |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$17
|
$157M |
2.0x |
-1.4x |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$3
|
$155M |
0.3x |
1.1x |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$152M |
N/A |
N/A |
INmune Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$149M |
14852.5x |
N/A |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$146M |
N/A |
-4.1x |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 23
|
$140M |
N/A |
N/A |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$124M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$118M |
17.0x |
-7.7x |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$114M |
180.6x |
-1.9x |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$113M |
5842.5x |
-0.4x |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 17
|
$111M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$108M |
N/A |
N/A |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$106M |
33.4x |
-0.4x |
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$101M |
64.5x |
-1.2x |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 7920
|
$101M |
N/A |
N/A |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$97.5M |
0.9x |
N/A |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€5
|
$93.5M |
1.2x |
2.4x |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$88.2M |
N/A |
N/A |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$77.8M |
2.7x |
N/A |
LakeShore Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$75.7M |
N/A |
N/A |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$73.7M |
4.1x |
-2.9x |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$15
|
$71.7M |
N/A |
N/A |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$66.0M |
N/A |
N/A |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$63.5M |
11096.8x |
-2.6x |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$48.1M |
10.8x |
N/A |
Vaxart
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$47.0M |
2.1x |
N/A |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€5
|
$41.5M |
N/A |
N/A |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$36.8M |
N/A |
N/A |
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$33.8M |
4.2x |
N/A |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$33.7M |
0.3x |
-0.9x |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$33.3M |
N/A |
N/A |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$28.4M |
2415.0x |
N/A |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$26.9M |
N/A |
-0.7x |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$26.8M |
N/A |
-1.2x |
Intensity Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$26.2M |
N/A |
N/A |
HCW Biologics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$19.3M |
20.1x |
N/A |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$18
|
$13.2M |
14.4x |
N/A |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$12.2M |
0.5x |
N/A |
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$9.6M |
N/A |
N/A |
Geovax Labs
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$1
|
$9.3M |
1.8x |
N/A |
Alligator Bioscience
|
Sweden |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
SEK 6
|
$8.5M |
1.2x |
-0.6x |
Adagene
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$5.4M |
64.5x |
-0.2x |
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$1.7M |
N/A |
0.0x |
Enlivex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$1.7M |
N/A |
N/A |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$2.2M |
-0.0x |
0.0x |
Affimed
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$3.0M |
-0.3x |
N/A |